MEDIATORN

The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.

In case of any discrepancies, please contact us at tel. +380 44 490 75 22

Solution for injection.

The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.

In case of any discrepancies, please contact us at tel. +380 44 490 75 22

  • Peripheral nervous system diseases: mono- and polyneuropathy, polyradyculopathy, myasthenia and myasthenic syndrome of various etiologies. Diseases of the central nervous system (CNS): bulbar paralysis and paresis; recovery period organic defeats of CNS, which are accompanied by movement disorders.
  • ipidacrine hydrochloride monohydrate, equivalent to ipidacrine hydrochloride – 15 mg; excipient: water for injections.

Buy from partners

From 0 uah

Order

Уточнюйте в аптеці

Order

Order

From 0 uah

Order
or order from partners

Уточнюйте в аптеці

Order

Legal Agreement for Information Access

This section contains information intended for healthcare institutions and professionals (hereinafter "licensed medical specialists") and includes specialized professional information about pharmaceuticals, including prescription medications. This information encompasses details such as drug names, descriptions, usage instructions, potential side effects, contraindications, and other professional information. The information is for informational purposes only and should not be used as a guide for self-diagnosis or treatment. Medication should be used only as directed by a physician, as self-treatment can be harmful to health.

Do you confirm that you have reviewed this restriction on information access and are a healthcare specialist?

No

Дякуємо за звернення!

Ваша форма успішно відправлена. Якщо у вас виникли додаткові питання, будь ласка, заповніть форму на сайті або зателефонуйте нам

Pharmacovigilance

If you have any information about an adverse reaction and/or lack of efficacy of an Arterium Corporation drug, please fill out the form: